Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bausch + Lomb Corporation (BLCO)
NYSE:BLCO
RESEARCH TOOLSreports
BLCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.16 - $21.69
Previous CloseN/A
Volume107.99K
Average Volume (3M)687.04K
Market Cap
$5.76B
Enterprise Value$11.18B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.82
Next Earnings
Apr 30, 2025EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.90
Shares Outstanding352,164,030
10 Day Avg. Volume922,489
30 Day Avg. Volume687,040
Standard Deviation0.09
R-Squared0.06
Alpha-0.00139
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.23
Price to Cash Flow (P/CF)9.40
P/FCF Ratio7.40
Enterprise Value/Market Cap1.94
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.46
Enterprise Value/Ebitda18.88
Forecast
1Y Price Target
$20.42Price Target Upside25.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
---
Bulls Say, Bears Say
Bulls Say
Product DevelopmentOJL332 has the potential to be the first-in-class therapy for chronic ocular surface pain, which has no FDA-approved treatment.
Revenue GrowthBLCO's top-line performance was solid, posting an estimated fourth-straight quarter of organic growth.
Bears Say
Strategic UncertaintyNo clear path to separating from parent Bausch Health Companies.
---
Ownership Overview
0.43% Insiders
0.30% Mutual Funds
7.11% Other Institutional Investors
92.04% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BLCO FAQ
What was Bausch + Lomb Corporation’s price range in the past 12 months?
Bausch + Lomb Corporation lowest stock price was $13.16 and its highest was $21.69 in the past 12 months.
What is Bausch + Lomb Corporation’s market cap?
Bausch + Lomb Corporation’s market cap is $5.76B.
When is Bausch + Lomb Corporation’s upcoming earnings report date?
Bausch + Lomb Corporation’s upcoming earnings report date is Apr 30, 2025 which is in 68 days.
How were Bausch + Lomb Corporation’s earnings last quarter?
Bausch + Lomb Corporation released its earnings results on Feb 19, 2025. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.02.
Is Bausch + Lomb Corporation overvalued?
According to Wall Street analysts Bausch + Lomb Corporation’s price is currently Undervalued.
Does Bausch + Lomb Corporation pay dividends?
Bausch + Lomb Corporation does not currently pay dividends.
What is Bausch + Lomb Corporation’s EPS estimate?
Bausch + Lomb Corporation’s EPS estimate is 0.05.
How many shares outstanding does Bausch + Lomb Corporation have?
Bausch + Lomb Corporation has 352,164,030 shares outstanding.
What happened to Bausch + Lomb Corporation’s price movement after its last earnings report?
Bausch + Lomb Corporation reported an EPS of $0.25 in its last earnings report, beating expectations of $0.23. Following the earnings report the stock price went down -0.306%.
Which hedge fund is a major shareholder of Bausch + Lomb Corporation?
Currently, no hedge funds are holding shares in BLCO
---
Bausch + Lomb Corporation Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.42 (25.28% Upside)
$20.42 (25.28% Upside)
Blogger Sentiment
Bullish
BLCO Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 4.3%
Last 30 Days ▲ 4.3%
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Negative
20 days / 200 days
Momentum
13.90%
12-Months-Change
Fundamentals
Return on Equity
-5.49%
Trailing 12-Months
Asset Growth
3.42%
Trailing 12-Months
Company Description
Bausch + Lomb Corporation
Bausch & Lomb Corp is a global eye health company dedicated towards protecting and enhancing the gift of sight for millions of people around the world. It holds portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments.
---
BLCO Company Deck
---
BLCO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted Bausch + Lomb's strong revenue growth across segments, successful product launches, and substantial innovation in their R&D pipeline. Despite challenges from currency headwinds and the Inflation Reduction Act, the company maintains a positive outlook with strategic investments in key products and technologies. The sentiment is largely positive with a focus on sustained growth and innovation.Read More>---
BLCO Stock 12 Month Forecast
Average Price Target
$20.42
▲(25.28% Upside)
Technical Analysis
Best Analysts Covering BLCO
1 Year
1 Year Success Rate
10/18 ratings generated profit
1 Year Average Return
+3.97%
reiterated a buy rating 2 days ago
Copying Douglas Miehm's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +3.97% per trade.
---